Join Servier as they award their 2026 Golden Ticket!

At this special pitch event, three finalist start ups will take the stage to present their groundbreaking research in oncology, neurology and the AI-enabled approaches advancing these fields. After the presentations, the panel of Servier judges will select one company as the winner of the 2026 Servier Golden Ticket!

The Golden Ticket provides a powerful launchpad for early stage companies, including:

• Access to LabCentral’s laboratory space in Cambridge, MA
• Mentorship and strategic support from Servier scientists and leadership
• A $50,000 credit toward LabCentral’s lab space and services

Join us for an exciting evening celebrating emerging biotech innovators as we hear from promising founders and announce the next recipient of the 2026 Servier Golden Ticket!